Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CV Sciences (CVSI) Operating Expenses (2016 - 2025)

CV Sciences' Operating Expenses history spans 14 years, with the latest figure at -$2.7 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 373.68% to -$2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $954000.0, a 81.84% decrease, with the full-year FY2025 number at $3.3 million, down 20.39% from a year prior.
  • Operating Expenses hit -$2.7 million in Q4 2025 for CV Sciences, down from $734000.0 in the prior quarter.
  • Over the last five years, Operating Expenses for CVSI hit a ceiling of $10.5 million in Q4 2021 and a floor of -$3.3 million in Q4 2023.
  • Historically, Operating Expenses has averaged $2.5 million across 5 years, with a median of $2.4 million in 2023.
  • Biggest five-year swings in Operating Expenses: surged 130.17% in 2024 and later crashed 373.68% in 2025.
  • Tracing CVSI's Operating Expenses over 5 years: stood at $10.5 million in 2021, then plummeted by 64.73% to $3.7 million in 2022, then tumbled by 190.18% to -$3.3 million in 2023, then surged by 130.17% to $1.0 million in 2024, then tumbled by 373.68% to -$2.7 million in 2025.
  • Business Quant data shows Operating Expenses for CVSI at -$2.7 million in Q4 2025, $734000.0 in Q3 2025, and $2.0 million in Q2 2025.